Analyze Estimates for the European, American & Japanese Apoptosis Related Therapeutic Products Market.DUBLIN, Ireland -- Research and Markets (http://www.researchandmarkets.com/reports/c49872) has announced the addition of Apoptosis Molecular Pathways to their offering. This market insight report gives an insight into Apoptosis Molecular Pathways - Caspase Activators and Inhibitors, Protease/Proteasome Inhibitors, Bcl-2 Modulators and p53 Modulators. The study also focuses on major diseases for which the treatment is based on apoptosis comprising Cancer, Neurodegenerative Diseases neurodegenerative diseases diseases characterized by neurodegeneration. Lesions are microscopic only but in chronic disease with massive involvement there may be grossly visible atrophy of affected nervous tissue. , Cardiovascular Diseases and other apoptosis based diseases including HIV HIV (Human Immunodeficiency Virus), either of two closely related retroviruses that invade T-helper lymphocytes and are responsible for AIDS. There are two types of HIV: HIV-1 and HIV-2. HIV-1 is responsible for the vast majority of AIDS in the United States. Infection, Organ Transplant organ transplant: see transplantation, medical. Rejection and MODS. The study provides global market analysis for apoptosis related therapeutic products by the above apoptosis molecular pathways and also by the disease areas. Estimates and projections for the total global apoptosis related therapeutic products market are given by geographic regions encompassing United States United States, officially United States of America, republic (2005 est. pop. 295,734,000), 3,539,227 sq mi (9,166,598 sq km), North America. The United States is the world's third largest country in population and the fourth largest country in area. , Europe, Japan and Rest of World. Business profiles of 41 major companies are discussed in the report. The report covers 247 companies that are engaged in apoptosis research, testing and supply of products and services. Major Contract Research Organizations and Universities serving apoptosis market are also covered in the Corporate Directory section of this report. Information related to product developments, partnerships, collaborations, and mergers and acquisitions is also included in the report. A total of 65 exhibits complement the text. RESEARCH SCOPE AND METHODOLOGY This report on Apoptosis Molecular Pathways is an ideal research tool providing strategic business intelligence. This report may help strategists, investors, laboratories, pharmaceutical companies, contract research organizations, biotechnology companies Top 100 Biotechnology Companies The following is a list of the top 100 biotechnology companies ranked by revenue. The first nine companies qualify for the list of the top 50 pharmaceutical companies. and drug approval authorities in - * Comprehending Key Market Drivers * Gauging Competitive Intelligence * Identifying Key Growth Areas and Opportunities * Understanding Geographic Relevance to Product * Knowing Regional Market Sizes and Growth Opportunities and Restraints * Keeping Tab on Emerging Technologies * Equity Analysis * Tapping New Markets Analytics and data presented in this report pertain to pertain to verb relate to, concern, refer to, regard, be part of, belong to, apply to, bear on, befit, be relevant to, be appropriate to, appertain to several parameters such as - * Global and Regional Market Sizes, Market Shares, Market Trends * Market Estimates and Forecasts * Product (Global and Regional) Market Sizes, Market Shares, Market Trends * Product / Technology Definitions / Research / Application Areas / Trends * Corporate Intelligence * Key Companies by Sales, Brands, Products * Key Player Profiles * Consumer Behavioral Patterns * Key Industry Developments (M&A activities, Collaborations, Licensing Agreements, Alliances, Research Agreements, R&D, etc.) * Market Growth Factors and Challenges * Market Drivers * Market Outlook * Other Strategic Business Affecting Data The report is distinguished for its - * Emphasis on Factual Insights and Forecasts * Maximum Global Coverage * Pure and Action Triggering Research and not Plain Reporting of Data * Strategic Information for Manufacturers, Retailers, Distributors, and Suppliers for Making and Supporting Critical Business Decisions Research Methodology for this report includes - : * Need and Scope of Study * Product Definitions * Segmental segmental /seg·men·tal/ (seg-men´t'l) 1. pertaining to or forming a segment or a product of division, especially into serially arranged or nearly equal parts. 2. undergoing segmentation. Analysis * Global and Regional Analysis * Exclusive Data Analytics * Corporate Intelligence * Feedback The day to day acceleration of developments in the industry sector has a powerful impact on the competitive landscape. Candid understanding of essential information can trigger successful business decisions. We are constantly monitoring the biotechnology industry, tracking market trends, and forecasting industry based on specialized analysis. The life sciences sector is an ever growing marketplace with emerging technologies in areas of discovery, design and development. Historic data helps in analyzing the future of the industry and is also helpful for doing market evaluations, and estimating the market size for the future. Every report is uniquely researched based on the type of market and is compiled using diligent analysis and research tools incorporating information from primary and secondary sources (online and offline). Feeds from the exclusive questionnaire and feedback forms customized for each report are used as information for authentication of our own findings. Secondary research includes government publications, investment research reports, web based Coming from a Web server. See Web application. surveys, website information of both companies and markets, and other offline resources such as print publications and CDs. Topics Covered I. SCOPE AND METHODOLOGY II. REPORT SYNOPSIS I. Foreword 2. Global Market Analysis 3. Regional Market Analysis III. PRODUCT RESEARCH 1. Introduction 2. Apoptosis Molecular Pathways 3. Disease Areas Connected with Apoptosis 4. Apoptosis Therapeutics IV. MARKET DYNAMICS 1. Market Overview 2. Major Companies in Apoptosis Market 3. Major Activities in Apoptosis Market 4. Regional Market Analysis 5. Apoptosis Molecular Pathways - The Market Outlook V. CORPORATE DIRECTORY Companies Mentioned - A.G. Scientific, Inc. (USA) - Abbott Laboratories Abbott Laboratories (NYSE: ABT) is a diversified pharmaceuticals and health care company. It has over 65,000 employees and operates in 130 countries. The corporate headquarters are in Abbott Park, Illinois, a neighborhood of North Chicago, Illinois. (USA) - Aegera Therapeutics, Inc. (Canada) - Aida Pharmaceuticals, Inc. (China) - Alexion Pharmaceuticals, Inc. (USA) - Alfacell Corporation (USA) - Amgen, Inc. (USA) - Antisoma plc (UK) - Applied Molecular Evolution (USA) - Ariad Pharmaceuticals, Inc. (USA) - ArQule, Inc (USA) - AVI BioPharma AVI BioPharma Inc. is a medical research and drug development company with corporate offices in Portland, Oregon, United States, and laboratories in Corvallis, Oregon. It was incorporated in 1980. Inc. (USA) - BD Biosciences (USA) - Cyclacel Pharmaceuticals, Inc. (USA) - Dendreon Corporation (USA) - D-Pharm Ltd. (Israel) - EntreMed, Inc. (USA) - EpiCept Corporation (USA) - F.Hoffmann-La Roche Ltd. (Switzerland) - Genta, Inc. (USA) - Genzyme Corporation (USA) - Incyte Corporation (USA) - Introgen Therapeutics, Inc. (USA) - Invitrogen, Inc. (USA) - ISIS Pharmaceuticals, Inc. (USA) - MGI MGI Mouse Genome Informatics MGI Modular Gateway Interface MGI McKinsey Global Institute MGI Military Geographic Information MGI Marine Geological Institute MGI Policy on the Management of Government Information (Canada) Pharma, Inc. (USA) - Millennium Pharmaceuticals Millennium Pharmaceuticals NASDAQ: MLNM is a biotechnology company based in the Cambridge, Massachusetts area of the United States of America. Founded in 1993, the company conducts research in various scientific areas, currently focusing on inflammation and oncology. Inc. (USA) - Novartis AG Novartis AG Swiss pharmaceutical company. It was formed through the 1996 merger of two Swiss firms: Ciba (see Ciba-Geigy) and Sandoz, a chemical company with interests in pharmaceuticals, nutrition, and agriculture. (Switzerland) - Novogen Limited (Australia) - Onyx Pharmaceuticals, Inc. (USA) - OSI Pharmaceuticals OSI Pharmaceuticals, Inc. is an American pharmaceutical company based in Long Island, New York with facilities in Colorado, New Jersey and the United Kingdom. They specialize in the discovery and development of molecular targeted therapies, and are listed in the NASDAQ , Inc. (USA) - Pfizer, Inc. (USA) - Pharmacyclics, Inc. (USA) - Schering-Plough Corporation (USA) - Sigma-Aldrich Corporation (USA) - Takeda Pharmaceutical Co., Ltd. (Japan) - Titan Pharmaceuticals The introduction to this article provides insufficient context for those unfamiliar with the subject matter. Please help [ improve the introduction] to meet Wikipedia's layout standards. You can discuss the issue on the talk page. Titan Pharmaceuticals, Inc. , Inc. (USA) - Vasogen, Inc. (Canada) - Vertex Pharmaceuticals Vertex Pharmaceuticals is a biotechnology company with activities spanning the length of the pharmaceutical product pipeline, from target identification through to clinical trials and marketing. , Inc. (USA) - Xenova Group Limited (UK) - Zentaris GmbH (Germany) For more information visit http://www.researchandmarkets.com/reports/c49872 |
|
||||||||||||
Printer friendly
Cite/link
Email
Feedback
Reader Opinion